Charcot-Marie-Tooth type 1A disease caused by a novel Ser112Arg mutation in thePMP22 gene, coexisting with a slowly progressive hearing impairment

Among 57 mutations in the peripheral myelin protein 22 gene (PMP22) identified so far in patients affected by Charcot-Marie-Tooth disease (CMT), only 8 have been shown to segregate with a mixed phenotype of CMT and hearing impairment. In this study, we report a new Ser1 12Arg mutation in thePMP22 gene, identified in a patient with early-onset CMT and slowly progressive hearing impairment beginning in the second decade of life. We suggest that the Ser1 12Arg mutation in thePMP22 gene might have a causative role in the early-onset CMT with hearing impairment. Thus, our study extends the spectrum of CMT phenotypes putatively associated withPMP22 gene mutations.

[1]  C. D. de Weerdt,et al.  Family with Charcot-Marie-Tooth disease showing unusual biochemical-clinical and genetic features. , 1974, European neurology.

[2]  N. Sambuughin,et al.  Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene , 2003, Neurology.

[3]  N. Aarskog,et al.  Real-time quantitative polymerase chain reaction , 2000, Human Genetics.

[4]  Aravinda Chakravarti,et al.  DNA duplication associated with Charcot-Marie-Tooth disease type 1A , 1991, Cell.

[5]  E. Jabs,et al.  A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness. , 1999, American journal of human genetics.

[6]  A. Gambardella,et al.  Hereditary demyelinating neuropathy of infancy: a genetically complex syndrome. , 1997, Brain : a journal of neurology.

[7]  L. Graziani,et al.  X-linked motor-sensory neuropathy type-II with deafness and mental retardation: a new disorder. , 1985, American journal of medical genetics.

[8]  J. Lupski,et al.  Charcot‐Marie‐Tooth disease and related neuropathies: Mutation distribution and genotype‐phenotype correlation , 2002, Annals of neurology.

[9]  U. Suter,et al.  Impaired Intracellular Trafficking Is a Common Disease Mechanism ofPMP22Point Mutations in Peripheral Neuropathies , 1999, Neurobiology of Disease.

[10]  C. Ploner,et al.  Novel mutations in the Charcot‐Marie‐Tooth disease genes PMP22, MPZ, and GJB1 , 2003, Human mutation.

[11]  U. Suter,et al.  Peripheral myelin protein 22: Facts and hypotheses , 1995, Journal of neuroscience research.

[12]  K. Huehne,et al.  Hearing loss as the first feature of late-onset axonal CMT disease due to a novel P0 mutation , 2004, Neurology.

[13]  F. Baas,et al.  Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a) , 1991, Neuromuscular Disorders.

[14]  A. Ishiyama,et al.  Dejerine–Sottas syndrome and vestibular loss due to a point mutation in the PMP22 gene , 2005, Journal of the Neurological Sciences.

[15]  N. Aarskog,et al.  Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. , 2000, Human genetics.

[16]  A. Hristova,et al.  Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24 , 1996, Nature Genetics.

[17]  C. Ki,et al.  A novel point mutation in PMP22 gene associated with a familial case of Charcot-Marie-Tooth disease type 1A with sensorineural deafness , 2004, Neuromuscular Disorders.